Veille Scientifique

La veille scientifique est un nouveau service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Cinq groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie Foie/
Voies bilaires
Gastro/Procto/
Pancréas/Nutrition
MICI
R. FAROUX P. PIENKOWSKI C. SILVAIN P. DUCROTTE P. SEKSIK
T. APARICIO
P. ARTRU
B. DENIS
A. LIEVRE
S. MANFREDI
D. TOUGERON
E. CORON
E. CHABRUN
F. ROSTAIN
JM. ROUILLON
B. HANSLIK
JL. PAYEN
JM. PERON
D. VALLA

F. CORDET
V. COSTIL
P. COULOM
P. JOUET
F. ZERBIB

P. FAURE
P. MARTEAU
S. NAHON

Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Gastroenterology Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer. sep. 16 4 ♥ Foie, Carcinome hépatocellulaire (CHC)
British journal of Cancer Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer sep. 16 2 ♥ Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires
Gastroenterology Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections. sep. 16 4 ♥ Foie
Gut Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety sep. 16 3 ♥ MICI
Gastroenterology Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-risk Users of Low-dose Aspirin sep. 16 2 ♥ Œsophage/Estomac
Gut A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals sep. 16 4 ♥ Endoscopie/Imagerie, Pancréas/Voies biliaires, Cancers autres (hors CCR et CHC)
Gut Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study sep. 16 4 ♥ Œsophage/Estomac
The Lancet Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. sep. 16 3 ♥ Foie
The Lancet The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. sep. 16 3 ♥ Foie
The Lancet Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. sep. 16 3 ♥ Foie
Journal of Hepatology Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy sep. 16 3 ♥ Foie
Hepatology Aspirin use and the risk of cholangiocarcinoma sep. 16 4 ♥ Foie, Cancers autres (hors CCR et CHC)
Journal of Hepatology Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens sep. 16 3 ♥ Hépatites virales, Foie
Journal of Hepatology First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B sep. 16 4 ♥ Hépatites virales, Foie
Journal of Hepatology Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study sep. 16 2 ♥ Hépatites virales, Foie
Journal of Hepatology Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity sep. 16 3 ♥ Hépatites virales, Foie
Journal of Hepatology Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis sep. 16 1 ♥ Hépatites virales, Foie
The American Journal of Gastroenterology The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies sep. 16 3 ♥ MICI
Gut Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort sep. 16 3 ♥ Foie
Journal of Hepatology Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study sep. 16 4 ♥ Foie
Journal of Hepatology Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis sep. 16 3 ♥ Foie
Journal of Hepatology Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury sep. 16 3 ♥ Hépatites virales, Foie
Hepatology Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis sep. 16 5 ♥ Foie
Hepatology Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma sep. 16 2 ♥ Carcinome hépatocellulaire (CHC)
Gut IOIBD technical review on endoscopic indices for Crohn’s disease clinical trials sep. 16 2 ♥ MICI

Pages